Stock listing

Lang & Schwarz:A3DVNM Oncodesign Precision Medicine S.A. Aktie

German listing (Lang & Schwarz) of Oncodesign Precision Medicine S.A. · home listing Euronext:ALOPM

Follow Oncodesign Precision Medicine S.A. into a list and get an email when it puts out news.

Home listing price · EURONEXT:ALOPM

€0.341 EUR +0.021 (+6.6%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:ALOPM

Ticker: Lang & Schwarz:A3DVNM
Asset type: Stock
Sector: Health care
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

What changed lately

Latest news release · Oct 7, 2026
OPM Achieved Several Major Scientific and Regulatory Milestones as Part of the LARKIN Program, Supported With Funding By The Michael J. Fox Foundation for Parkinson's Research (MJFF)

Latest news

OPM Achieved Several Major Scientific and Regulatory Milestones as Part of the LARKIN Program, Supported With Funding By The Michael J. Fox Foundation for Parkinson's Research (MJFF)

Oct 7, 2026

OPM Announces Its 2025 Annual Results and Provides an Update on Its Clinical Developments

Apr 30, 2026

Oncodesign Precision Medicine Receives Support from The Michael J. Fox Foundation to Advance Development of LRRK2 Inhibitor OPM-201 for Parkinson’s Disease

Mar 3, 2026

Oncodesign Precision Medicine and Ksilink Join Forces to Test the Nanocyclix® Chemical Library in Cell Models Derived From Patients With Serious Central Nervous System Diseases

Jan 8, 2026

Oncodesign Precision Medicine and Navigo Proteins Announce the End of Their Collaboration in the Development of Radiotheranostics

Dec 29, 2025

OPM Obtains Development Grants From the Bourgogne Franche-Comté Region

Oct 14, 2025

OPM Publishes Its 2025 Half-Yearly Report

Oct 9, 2025

OPM Integrated Into the LRRK2 Investigative Therapeutics Exchange Program From the Michael J. Fox Foundation for Parkinson’s Research

Sep 25, 2025

OPM Announces Its 2025 Half-Year Financial Results and Provides an Update on Its Clinical Developments and Financial Position

Jul 31, 2025

Oncodesign Precision Medicine Announces Equity Financing of up to 5 Million Euros

Apr 17, 2025

All Oncodesign Precision Medicine S.A. news

Decks

Investor Day (December 2023)
Investor day · 62 slides · Dec 5, 2023

Oncodesign Precision Medicine S.A. on 6ix

Sector: Health care
Industry: Biotechnology
News releases: 6 in the last 12 months · 20 in all · newest Oct 7, 2026 · oldest 2024
Decks: 1 deck · latest Dec 5, 2023

Where Oncodesign Precision Medicine S.A. is listed

Listing	Exchange	Country	Currency
Euronext:ALOPM · Home listing	Euronext	France	EUR
Lang & Schwarz:A3DVNM · This page	Lang & Schwarz	Germany	EUR
LS Exchange:A3DVNM	LS Exchange	Germany	EUR
Frankfurt:ZR8	Frankfurt	Germany	EUR
Stuttgart:ZR8	Stuttgart	Germany	EUR

Log in to ask 6ix AI your own questions about Oncodesign Precision Medicine S.A.